Curcumin ameliorates intrahepatic angiogenesis and capillarization of the sinusoids in carbon tetrachloride-induced rat liver fibrosis (Q42710296)

5 November 2017

title

Curcumin ameliorates intrahepatic angiogenesis and capillarization of the sinusoids in carbon tetrachloride-induced rat liver fibrosis (English)

1 reference

5 November 2017

0 references

Qunyan Yao

1

1 reference

5 November 2017

Yizheng Lin

2

1 reference

5 November 2017

Xi Li

3

1 reference

5 November 2017

Xizhong Shen

4

1 reference

5 November 2017

Jiyao Wang

5

1 reference

5 November 2017

Chuantao Tu

6

1 reference

5 November 2017

publication date

8 July 2013

1 reference

5 November 2017

1 reference

5 November 2017

volume

222

1 reference

5 November 2017

issue

1

1 reference

5 November 2017

page(s)

72-82

1 reference

Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis.

5 November 2017

cites work

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Pharmacological actions of curcumin in liver diseases or damage.

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Mechanisms of hepatic fibrogenesis

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Myofibroblasts in the cirrhotic rat liver reflect hepatic remodeling and correlate with fibrosis and sinusoidal capillarization

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

A polymeric nanoparticle formulation of curcumin (NanoCurc™) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation.

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Mechanisms of hepatic fibrogenesis

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Prevention of liver cirrhosis in rats by curcumin

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Capillarization of Hepatic Sinusoid by Liver Endothelial Cell-Reactive Autoantibodies in Patients with Cirrhosis and Chronic Hepatitis

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Hypoxia-inducible factor-1α regulates the expression of genes in hypoxic hepatic stellate cells important for collagen deposition and angiogenesis

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Angiogenesis in chronic liver disease and its complications

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Classification of chronic viral hepatitis: a need for reassessment

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Arsenic requires sphingosine-1-phosphate type 1 receptors to induce angiogenic genes and endothelial cell remodeling

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Targeting the tumour vasculature: insights from physiological angiogenesis

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Liver fibrosis: from the bench to clinical targets

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Protective effects of curcumin against hepatic fibrosis induced by carbon tetrachloride: modulation of high-mobility group box 1, Toll-like receptor 4 and 2 expression

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Hypoxic stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cells

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Angiogenesis in chronic inflammatory liver disease

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Hepatic microvascular features in experimental cirrhosis: a structural and morphometrical study in CCl4-treated rats

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: New targets for the treatment of portal hypertension?

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Curcumin attenuates Concanavalin A-induced liver injury in mice by inhibition of Toll-like receptor (TLR) 2, TLR4 and TLR9 expression

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TOXLET.2013.06.240

Identifiers

DOI

10.1016/J.TOXLET.2013.06.240

1 reference

5 November 2017

1 reference